… TRAIL- and chemotherapy-induced cell killing. Conclusions: This study demonstrates that
combination treatment of prostate cancer cells with TRAIL and chemotherapeutic agents …

… Advanced prostate cancer is also associated with a state of high oxidative stress (Yossepowitch
et al. Citation2007), suggesting that the prostate cancer cell lines used in this study …

… The drawback of this technique is that cell lines may not reflect diol with the alkylating
agent nor-nitrogen mustard, waschosenforcombinationstudiesbecauseofitsclinical the clinical …

… model for prostate cancer using xenografted mice. This study demonstrates that … treatment
of prostate cancer cells with chemotherapeutic agents (microtubule and DNA damaging drugs) …

… Our results indicate that the induction of C/EBPb renders prostate cancer cells more
susceptible to the cytotoxic effects of chemotherapeutic agents. Although induction of C/EBPb was …

… effects of rapamycin in both prostate cancer cell lines, and … chemotherapeutic agents
was more effective in PC-3 cells … treatment with Fe 3 O 4 NPs and rapamycin in PC-3 cells …

… Prostatic tissue samples … prostatic hyperplasia (BPH) or prostate carcinoma (PC), in our
Institutional Hospital. None of these patients were under any hormonal or chemotherapeutic …

… of PCA cells (5–8). This mechanism may sensitize cancer cells to chemotherapeutic drugs.
… efficacy of several cancer therapeutic drugs in human prostate carcinoma DU145 and PC-3 …

… carcinomas that are refractory to various chemotherapeutic agents.Recently it is demanded
to search effective chemotherapeutic agents for treatment of these prostate cancers, either …

… Cell Lines The human androgen-independent LNCaP prostate cancer cell line that we
used in this study was described previously (18). LNCaP cells were grown in RPMI 1640 …